ALKAL2, also named augmentor-α (AUG-α) or FAM150b, was first described in the adrenal gland (26) and the retina (45), where its signaling through ALK and LTK receptors has been implicated in autoimmunity, neurodevelopment, and cancer. Here, ALKAL2 is linked to cancer.